← Leaderboards
Myriam Marianne Chaumeil
University Of California, San Francisco
$7,418,051
Attributed
$14,128,231
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2016–24$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,128,231 · 9
By mechanism
R01$5,516,586 · 3
RF1$3,597,332 · 1
R33$2,624,637 · 1
R21$1,323,979 · 3
R61$1,065,697 · 1
Top collaborators
- Scott Earley7 shared
- Douglas Gould7 shared
- James Louis Rubenstein5 shared
- Caroline Guglielmetti2 shared
- Susanna Rosi2 shared
- Jeremy William Gordon1 shared
- Ken Nakamura1 shared
- David M Wilson1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Ellen M. Mowry$4,947,183
- Douglas Gould$18,350,835
- David M Wilson$11,449,852
- Jeremy William Gordon$6,602,958
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposImaging ModalityEvaluationMagnetic Resonance ImagingImageBrainIn VivoMetabolicLesionMonitorImaging ApproachDetectionRegimenValidationBiological MarkersLeadPre-Clinical ModelPathway InteractionsCognitiveInnovationMetabolic ImagingPyruvateImaging StudyResponse
Grant awards (25)
Theranostic Metabolic Imaging of Oxidative Stress in Multiple Sclerosis.$201,875
R21 · FY2024 · AI · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$783,698
R33 · FY2023 · NS
Imaging cerebral metabolic impairment in AD using Deuterium MRI$719,216
R01 · FY2023 · AG · contact PI
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma$571,523
R01 · FY2023 · CA
Theranostic Metabolic Imaging of Oxidative Stress in Multiple Sclerosis.$242,250
R21 · FY2023 · AI · contact PI
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$155,505
R33 · FY2023 · NS
Diversity Supplement-Massoudi$106,768
R33 · FY2023 · NS
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$782,056
R33 · FY2022 · NS
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma$584,054
R01 · FY2022 · CA
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$796,610
R33 · FY2021 · NS
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma$613,413
R01 · FY2021 · CA
MR metabolic Imaging of Multiple Sclerosis$346,719
R01 · FY2021 · NS · contact PI
Imaging innate and adaptive immune response in MS using using [18F]F-AraG PET and hyperpolarized 13C MRSI$161,500
R21 · FY2021 · AI · contact PI
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma$644,765
R01 · FY2020 · CA
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$560,704
R61 · FY2020 · NS
MR metabolic Imaging of Multiple Sclerosis$346,719
R01 · FY2020 · NS · contact PI
Imaging innate and adaptive immune response in MS using using [18F]F-AraG PET and hyperpolarized 13C MRSI$282,479
R21 · FY2020 · AI · contact PI
Understand and probing disrupted glucose metabolism in Alzheimer's disease$3,597,332
RF1 · FY2019 · AG
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma$650,020
R01 · FY2019 · CA
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment$504,993
R61 · FY2019 · NS
MR metabolic Imaging of Multiple Sclerosis$346,719
R01 · FY2019 · NS · contact PI
MR metabolic Imaging of Multiple Sclerosis$346,719
R01 · FY2018 · NS · contact PI
MR metabolic Imaging of Multiple Sclerosis$346,719
R01 · FY2017 · NS · contact PI
In vivo metabolic imaging of neuroinflammation after TBI$198,125
R21 · FY2017 · NS
In vivo metabolic imaging of neuroinflammation after TBI$237,750
R21 · FY2016 · NS